Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00456144 · ClinicalTrials.gov registry record
Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate Cancer
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 36
- Enrollment target
NCT00456144: Completed study, sponsored by Massachusetts General Hospital.
NCT00456144 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00456144 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The purpose of this research study is to find out if a certain type of hormone therapy, gonadotropin-releasing hormone agonist (GnRH agonist), affects the way the body produces and responds to insulin. The investigators will evaluate the changes in insulin sensitivity during and after GnRH agonist treatment for prostate cancer. The investigators are assessing the possibility that treatment-related insulin resistance may contribute to the risk of diabetes and/or cardiovascular disease in men with prostate cancer.
Interventions
- DRUG Gonadotropin Releasing Hormone Agonist Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2006-08 |
| Est. Completion | 2012-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00456144
The ClinicalTrials.gov registry entry for NCT00456144 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gonadotropin Releasing Hormone Agonist Therapy is the first listed.
NCT00456144 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00456144 about?
NCT00456144 is a clinical study titled "Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate Cancer". The purpose of this research study is to find out if a certain type of hormone therapy, gonadotropin-releasing hormone agonist (GnRH agonist), affects the way the body produces and responds to insulin. The investigators will evaluate the changes in insulin sensitivity during and after GnRH agonist t...
What is the current status of trial NCT00456144?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2006-08. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00456144?
The interventions under investigation include: Gonadotropin Releasing Hormone Agonist Therapy (DRUG).
Who is sponsoring clinical trial NCT00456144?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.